Study protocol: the DOse REsponse Multicentre International collaborative initiative (DO-RE-MI).

Detalhes bibliográficos
Autor(a) principal: Kindgen-Milles, D.
Data de Publicação: 2005
Outros Autores: Journois, D., Fumagalli, R., Vesconi, S., Maynar, J., Marinho, A., Bolgan, I., Brendolan, A., Formica, M., Livigni, S., Maio, M., Marchesi, M., Mariano, F., Monti, G., Moretti, E., Silengo, D., Ronco, C.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.16/544
Resumo: We found 1 article by title matching your search: Crit Care. 2005 Aug;9(4):R396-406. Epub 2005 Jun 14. Study protocol: the DOse REsponse Multicentre International collaborative initiative (DO-RE-MI). Kindgen-Milles D, Journois D, Fumagalli R, Vesconi S, Maynar J, Marinho A, Bolgan I, Brendolan A, Formica M, Livigni S, Maio M, Marchesi M, Mariano F, Monti G, Moretti E, Silengo D, Ronco C. Anesthesiology Clinic, University of Düsseldorf, Germany. Kindgen-Milles@med.uni-duesseldorf.de Abstract INTRODUCTION: Current practices for renal replacement therapy in intensive care units (ICUs) remain poorly defined. The DOse REsponse Multicentre International collaborative initiative (DO-RE-MI) will address the issue of how the different modes of renal replacement therapy are currently chosen and performed. Here, we describe the study protocol, which was approved by the Scientific and Steering Committees. METHODS: DO-RE-MI is an observational, multicentre study conducted in ICUs. The primary end-point will be the delivered dose of dialysis, which will be compared with ICU mortality, 28-day mortality, hospital mortality, ICU length of stay and number of days of mechanical ventilation. The secondary end-point will be the haemodynamic response to renal replacement therapy, expressed as percentage reduction in noradrenaline (norepinephrine) requirement. Based on the the sample analysis calculation, at least 162 patients must be recruited. Anonymized patient data will be entered online in electronic case report forms and uploaded to an internet website. Each participating centre will have 2 months to become acquainted with the electronic case report forms. After this period official recruitment will begin. Patient data belong to the respective centre, which may use the database for its own needs. However, all centres have agreed to participate in a joint effort to achieve the sample size needed for statistical analysis. CONCLUSION: The study will hopefully help to collect useful information on the current practice of renal replacement therapy in ICUs. It will also provide a centre-based collection of data that will be useful for monitoring all aspects of extracorporeal support, such as incidence, frequency, and duration. PMID: 16137353 [PubMed - indexed for MEDLINE]PMCID: PMC1269446Free PMC Article Images from this publication.See all images (4) Free text Figure 1Flowchart of the DO-RE-MI observational study. All incident patients admitted to the intensive care unit (ICU) and requiring renal replacement therapy (RRT) will be followed up during RRT. At discharge, primary and secondary end-points will be recorded. All data will be entered in electronic case re...Study protocol: The DOse REsponse Multicentre International collaborative initiative (DO-RE-MI)Crit Care. 2005;9(4):R396-R406.
id RCAP_c293f5c065771d6d51cc3a8d6626825e
oai_identifier_str oai:repositorio.chporto.pt:10400.16/544
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Study protocol: the DOse REsponse Multicentre International collaborative initiative (DO-RE-MI).We found 1 article by title matching your search: Crit Care. 2005 Aug;9(4):R396-406. Epub 2005 Jun 14. Study protocol: the DOse REsponse Multicentre International collaborative initiative (DO-RE-MI). Kindgen-Milles D, Journois D, Fumagalli R, Vesconi S, Maynar J, Marinho A, Bolgan I, Brendolan A, Formica M, Livigni S, Maio M, Marchesi M, Mariano F, Monti G, Moretti E, Silengo D, Ronco C. Anesthesiology Clinic, University of Düsseldorf, Germany. Kindgen-Milles@med.uni-duesseldorf.de Abstract INTRODUCTION: Current practices for renal replacement therapy in intensive care units (ICUs) remain poorly defined. The DOse REsponse Multicentre International collaborative initiative (DO-RE-MI) will address the issue of how the different modes of renal replacement therapy are currently chosen and performed. Here, we describe the study protocol, which was approved by the Scientific and Steering Committees. METHODS: DO-RE-MI is an observational, multicentre study conducted in ICUs. The primary end-point will be the delivered dose of dialysis, which will be compared with ICU mortality, 28-day mortality, hospital mortality, ICU length of stay and number of days of mechanical ventilation. The secondary end-point will be the haemodynamic response to renal replacement therapy, expressed as percentage reduction in noradrenaline (norepinephrine) requirement. Based on the the sample analysis calculation, at least 162 patients must be recruited. Anonymized patient data will be entered online in electronic case report forms and uploaded to an internet website. Each participating centre will have 2 months to become acquainted with the electronic case report forms. After this period official recruitment will begin. Patient data belong to the respective centre, which may use the database for its own needs. However, all centres have agreed to participate in a joint effort to achieve the sample size needed for statistical analysis. CONCLUSION: The study will hopefully help to collect useful information on the current practice of renal replacement therapy in ICUs. It will also provide a centre-based collection of data that will be useful for monitoring all aspects of extracorporeal support, such as incidence, frequency, and duration. PMID: 16137353 [PubMed - indexed for MEDLINE]PMCID: PMC1269446Free PMC Article Images from this publication.See all images (4) Free text Figure 1Flowchart of the DO-RE-MI observational study. All incident patients admitted to the intensive care unit (ICU) and requiring renal replacement therapy (RRT) will be followed up during RRT. At discharge, primary and secondary end-points will be recorded. All data will be entered in electronic case re...Study protocol: The DOse REsponse Multicentre International collaborative initiative (DO-RE-MI)Crit Care. 2005;9(4):R396-R406.BioMed CentralRepositório Científico da Unidade Local de Saúde de Santo AntónioKindgen-Milles, D.Journois, D.Fumagalli, R.Vesconi, S.Maynar, J.Marinho, A.Bolgan, I.Brendolan, A.Formica, M.Livigni, S.Maio, M.Marchesi, M.Mariano, F.Monti, G.Moretti, E.Silengo, D.Ronco, C.2011-03-02T12:23:56Z2005-082005-08-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.16/544eng1364-8535info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-11-21T05:00:10Zoai:repositorio.chporto.pt:10400.16/544Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-11-21T05:00:10Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Study protocol: the DOse REsponse Multicentre International collaborative initiative (DO-RE-MI).
title Study protocol: the DOse REsponse Multicentre International collaborative initiative (DO-RE-MI).
spellingShingle Study protocol: the DOse REsponse Multicentre International collaborative initiative (DO-RE-MI).
Kindgen-Milles, D.
title_short Study protocol: the DOse REsponse Multicentre International collaborative initiative (DO-RE-MI).
title_full Study protocol: the DOse REsponse Multicentre International collaborative initiative (DO-RE-MI).
title_fullStr Study protocol: the DOse REsponse Multicentre International collaborative initiative (DO-RE-MI).
title_full_unstemmed Study protocol: the DOse REsponse Multicentre International collaborative initiative (DO-RE-MI).
title_sort Study protocol: the DOse REsponse Multicentre International collaborative initiative (DO-RE-MI).
author Kindgen-Milles, D.
author_facet Kindgen-Milles, D.
Journois, D.
Fumagalli, R.
Vesconi, S.
Maynar, J.
Marinho, A.
Bolgan, I.
Brendolan, A.
Formica, M.
Livigni, S.
Maio, M.
Marchesi, M.
Mariano, F.
Monti, G.
Moretti, E.
Silengo, D.
Ronco, C.
author_role author
author2 Journois, D.
Fumagalli, R.
Vesconi, S.
Maynar, J.
Marinho, A.
Bolgan, I.
Brendolan, A.
Formica, M.
Livigni, S.
Maio, M.
Marchesi, M.
Mariano, F.
Monti, G.
Moretti, E.
Silengo, D.
Ronco, C.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório Científico da Unidade Local de Saúde de Santo António
dc.contributor.author.fl_str_mv Kindgen-Milles, D.
Journois, D.
Fumagalli, R.
Vesconi, S.
Maynar, J.
Marinho, A.
Bolgan, I.
Brendolan, A.
Formica, M.
Livigni, S.
Maio, M.
Marchesi, M.
Mariano, F.
Monti, G.
Moretti, E.
Silengo, D.
Ronco, C.
description We found 1 article by title matching your search: Crit Care. 2005 Aug;9(4):R396-406. Epub 2005 Jun 14. Study protocol: the DOse REsponse Multicentre International collaborative initiative (DO-RE-MI). Kindgen-Milles D, Journois D, Fumagalli R, Vesconi S, Maynar J, Marinho A, Bolgan I, Brendolan A, Formica M, Livigni S, Maio M, Marchesi M, Mariano F, Monti G, Moretti E, Silengo D, Ronco C. Anesthesiology Clinic, University of Düsseldorf, Germany. Kindgen-Milles@med.uni-duesseldorf.de Abstract INTRODUCTION: Current practices for renal replacement therapy in intensive care units (ICUs) remain poorly defined. The DOse REsponse Multicentre International collaborative initiative (DO-RE-MI) will address the issue of how the different modes of renal replacement therapy are currently chosen and performed. Here, we describe the study protocol, which was approved by the Scientific and Steering Committees. METHODS: DO-RE-MI is an observational, multicentre study conducted in ICUs. The primary end-point will be the delivered dose of dialysis, which will be compared with ICU mortality, 28-day mortality, hospital mortality, ICU length of stay and number of days of mechanical ventilation. The secondary end-point will be the haemodynamic response to renal replacement therapy, expressed as percentage reduction in noradrenaline (norepinephrine) requirement. Based on the the sample analysis calculation, at least 162 patients must be recruited. Anonymized patient data will be entered online in electronic case report forms and uploaded to an internet website. Each participating centre will have 2 months to become acquainted with the electronic case report forms. After this period official recruitment will begin. Patient data belong to the respective centre, which may use the database for its own needs. However, all centres have agreed to participate in a joint effort to achieve the sample size needed for statistical analysis. CONCLUSION: The study will hopefully help to collect useful information on the current practice of renal replacement therapy in ICUs. It will also provide a centre-based collection of data that will be useful for monitoring all aspects of extracorporeal support, such as incidence, frequency, and duration. PMID: 16137353 [PubMed - indexed for MEDLINE]PMCID: PMC1269446Free PMC Article Images from this publication.See all images (4) Free text Figure 1Flowchart of the DO-RE-MI observational study. All incident patients admitted to the intensive care unit (ICU) and requiring renal replacement therapy (RRT) will be followed up during RRT. At discharge, primary and secondary end-points will be recorded. All data will be entered in electronic case re...Study protocol: The DOse REsponse Multicentre International collaborative initiative (DO-RE-MI)Crit Care. 2005;9(4):R396-R406.
publishDate 2005
dc.date.none.fl_str_mv 2005-08
2005-08-01T00:00:00Z
2011-03-02T12:23:56Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.16/544
url http://hdl.handle.net/10400.16/544
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1364-8535
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv mluisa.alvim@gmail.com
_version_ 1817549551335112704